• adjuvant therapies
• anti-inflammatoty and immuno-therapy
• anti-inflammatory therapies
• anti GM-CSF
• mavrilimumab
• Namilumab
• otilimab
• clarithromycine
• colchicine
• Colchicine plus rosuvastatin
• mepolizumab
• naproxen, ibuprofen
• non-steroidal anti-inflammatory drugs
• Celecoxib
• Ibuprofen
• Indomethacin
• selinexor
• sodium aescinate
• stem cells
• tradipitant
• vilobelimab (IFX-1)
• Apilimod
• corticosteroids
• ciclesonide
• dexamethasone
• Dexamethasone 12mg
• dexamethasone 6mg
• Hydrocortisone
• low-dose corticosteroids
• methylprednisolone
• Immunostimulants drugs
• anti-PD-1 antibody
• CD24Fc
• convalescent plasma treatment
• Deferred Convalescent plasma
• Early convalescent plasma.
• immunoglobulin therapy
• inactivated mycobacterium vaccine
• interferon
• IFN beta-1a
• high-dose IFN beta-1a
• IFN beta-1b
• IFN gamma
• inhaled interferon
• IFN alpha
• pegylated interferon-α2b
• recombinant super-compound interferon rSIFN-co
• SNG001 inhaled interferon beta
• interferon / TFF2
• peginterferon
• PNB001
• Interleukin-2
• levamisole
• neutralizing antibody
• amubarvimab/romlusevimab (BRII-196 and BRII-198-Brii Biosciences)
• bamlanivimab monotherapy
• bamlanivimab/etesevimab
• Bebtelovimab (LY-CoV1404)
• bevacizumab
• casirivimab/imdevimab (Ronapreve)
• cilgavimab and tixagevimab (Evusheld)
• equine polyclonal antibodies INM005
• regdanvimab (Regkirona- CT-P59-Celltrion)
• sotrovimab (Xevudy; VIR-7831)
• XAV-19
• rhG-CSF
• Immunosuppressants drugs
• abatacept
• adalimumab
• anakinra
• anti-interleukin-6
• clazakizumab
• Levilimab
• sarilumab
• sarilumab azithromycin hydroxychloroquine
• sarilumab high dose (400mg)
• sarilumab low dose (200mg)
• siltuximab
• tocilizumab
• canakinumab
• cenicriviroc
• complement inhibitors
• conestat alfa
• ravulizumab
• CRAC-channel inhibitors (auxora)
• eculizumab
• emapalumab
• fostamatinib
• infliximab
• itolizumab
• ixekizumab
• jakotinib
• janus kinase (JAK) inhibitor
• baricitinib
• baricitinib plus remdesivir
• ruxolitinib
• TD-0903
• TD-0903 10mg
• TD-0903 1mg
• TD-0903 3mg
• tofacitinib
• lenzilumab
• pamrevlumab
• tacrolimus
• tetrandrine
• thalidomide
• inhaled corticosteroids
• budesonide
• Kinase inhibitors
• acalabrutinib
• imatinib
• leflunomide
• meplazumab
• pirfenidone
• Polyinosinic-Polycytidylic Acid
• sargramostim
• statins
• Atorvastatin
• thymosin
• antiandrogenic
• antiviral and associated therapy
• control
• Drugs for acid related disorders
• miscellaneous
• Oral antidiabetic drugs
• Renin-angiotensin-system-acting agents
• vaccines
• Vitamins

• COVID 19 hospitalized
• COVID 19 all comers
• COVID-19 mild to moderate
• COVID-19 severe or critically
• COVID 19 outpatients
• COVID-19 (hospitalized or not)
• COVID-19 prophylaxis (children)
• COVID-19 prophylaxis (excluding children)
• infections other than COVID-19
• Long COVID-19
• preventing respiratory virus transmission
• secondary prevention